Voriconazole Susceptibilities of Dermatophyte Isolates Obtained from a Worldwide Tinea Capitis Clinical Trial | Zendy

Mahmoud Ghannoum | Zendy; N. Isham | Zendy; Daniel F. Sheehan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Voriconazole Susceptibilities of Dermatophyte Isolates Obtained from a Worldwide Tinea Capitis Clinical Trial

Author(s) -

Mahmoud Ghannoum,

N. Isham,

Daniel F. Sheehan

Publication year - 2006

Publication title -

journal of clinical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.349

H-Index - 255

eISSN - 1070-633X

pISSN - 0095-1137

DOI - 10.1128/jcm.00818-06

Subject(s) - dermatophyte , voriconazole , griseofulvin , fluconazole , tinea capitis , medicine , itraconazole , mycosis , dermatology , microbiology and biotechnology , antifungal , biology , surgery

In this study, the voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis trial were compared to their susceptibilities to fluconazole and griseofulvin. The MIC ranges of voriconazole, fluconazole, and griseofulvin, were 0.002 to 0.06 μg/ml, 0.25 to 32 μg/ml, and 0.125 to 2.0 μg/ml, respectively.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research